Investing in Puma Biotechnology Inc [PBYI]: What You Must Know

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Puma Biotechnology Inc shares valued at $90,909 were sold by Cesano Alessandra on Jul 18 ’25. At $3.37 per share, Cesano Alessandra sold 27,000 shares. The insider’s holdings dropped to 41,850 shares worth approximately $0.14 million following the completion of this transaction.

Also, Cesano Alessandra purchased 27,000 shares, netting a total of over 90,909 in proceeds.

Before that, NOUGUES MAXIMO F had sold 5,587 shares from its account. In a trade valued at $19,739, the Chief Financial Officer traded Puma Biotechnology Inc shares for $3.53 each. Upon closing the transaction, the insider’s holdings decreased to 5,587 shares, worth approximately $0.68 million.

As published in a research note from Citigroup on September 28, 2021, Puma Biotechnology Inc [PBYI] has been rated up from a Neutral to a Buy and the price target has been revised to $11. As of October 08, 2019, Goldman has decreased its “Neutral” rating to a “Sell” for PBYI. Earlier on May 10, 2019, Citigroup downgraded its rating. Their new recommendation was “a Neutral” for PBYI stock which previously was a “a Buy”.

Analyzing PBYI Stock Performance

On last trading session, Puma Biotechnology Inc [NASDAQ: PBYI] rose 1.23% to $3.29. The stock’s lowest price that day was $3.215, but it reached a high of $3.32 in the same session. During the last five days, there has been a surge of approximately 5.79%. Over the course of the year, Puma Biotechnology Inc shares have dropped approximately -8.36%.

Is Puma Biotechnology Inc subject to short interest?

Stocks of Puma Biotechnology Inc saw a sharp steep in short interest on 2025-07-15 dropping by 71027.0 shares to 2.61 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 2.68 million shares. A decline of -2.73% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.06 of the overall float, the days-to-cover ratio (short ratio) decline to 8.06.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.